89bio, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2019 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
89bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2019 to Q2 2024.
- 89bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $5.17M, a 24.9% increase year-over-year.
- 89bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $18.6M, a 43.6% increase year-over-year.
- 89bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $16.1M, a 55.5% increase from 2022.
- 89bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10.4M, a 19.3% increase from 2021.
- 89bio, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $8.68M, a 128% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)